First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor

Clinical trial NCT07755397 · RECRUITING

Trial details

NCT number: NCT07755397
Sponsor: Jubilant Therapeutics India Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

NSCLC Patients With EGFR Activating Mutation Adenoid Cystic Carcinoma Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Start date: 2024-08-26
Primary completion: 2028-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.